Acura Pharmaceuticals Inc (ACUR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2003 | 12-2002 | 09-2002 | 06-2002 | 03-2002 | |
| Sales | 1,526 | 2,053 | 2,013 | 2,258 | 1,881 |
| Cost of Goods | 2,873 | 3,163 | 3,118 | 3,353 | 2,901 |
| Gross Profit | -1,347 | -1,110 | -1,105 | -1,095 | -1,020 |
| Operating Expenses | 8,680 | -5,305 | 5,666 | 5,477 | 4,304 |
| Operating Income | -9,154 | 4,358 | -6,653 | -6,219 | -4,423 |
| Interest Expense | 1,433 | 1,320 | 1,235 | 1,135 | 1,038 |
| Other Income | 12 | -41,939 | 19 | 14 | -18 |
| Pre-tax Income | -10,575 | -38,901 | -7,869 | -7,340 | -5,479 |
| Net Income Continuous | -10,575 | -38,901 | -7,869 | -7,340 | -5,479 |
| Net Income | $-10,575 | $-38,901 | $-7,869 | $-7,340 | $-5,479 |
| EPS Basic Total Ops | -25.00 | -126.50 | -26.00 | -24.50 | -18.00 |
| EPS Basic Continuous Ops | -25.14 | -126.56 | -26.12 | -24.36 | -18.18 |
| EPS Diluted Total Ops | -25.00 | -126.50 | -26.00 | -24.50 | -18.00 |
| EPS Diluted Continuous Ops | -25.14 | -126.56 | -26.12 | -24.36 | -18.18 |
| EBITDA(a) | $-3,174 | $9,558 | $-3,249 | $-3,193 | $-2,623 |